mbc: cdk4/6 inhibitor patient selection/sequencing
Published 6 years ago • 281 plays • Length 3:38Download video MP4
Download video MP3
Similar videos
-
8:42
hr mbc: treatment after progression on cdk4/6 inhibition
-
6:28
cdk4/6 inhibitors: managing toxicity in hr mbc
-
6:18
hr mbc: factors in selecting cdk4/6 inhibitions
-
6:19
selecting agents in cdk4/6 inhibition for hr mbc
-
8:24
cdk4/6 inhibition in hormone receptor-positive mbc
-
6:41
differences among cdk4/6 inhibitors in hr mbc
-
4:15
hr breast cancer: factors in selecting a cdk4/6 inhibitor
-
3:44
questioning cdk4/6 inhibitor cross-resistance in hr mbc
-
5:31
efficacy of cdk4/6 inhibitors in hr mbc
-
6:54
current state of cdk4/6 inhibition in hr mbc
-
7:19
biomarkers for cdk4/6 inhibitors in hr mbc
-
8:28
fulvestrant in the era of cdk4/6 inhibitors for hr mbc
-
7:45
do cdk4/6 inhibitors impact later therapy in hr mbc?
-
3:04
optimizing cdk4/6 inhibition in hr breast cancer
-
7:17
abemaciclib for er mbc
-
7:16
cdk4/6 inhibitors in hormone receptor-driven mbc
-
3:27
metastatic breast cancer: cdk4/6 inhibitors
-
6:11
hr metastatic breast cancer: upfront cdk4/6 inhibition
-
6:05
cdk4/6 inhibitors & endocrine therapy: selecting a regimen